Photoprotective behaviour and sunscreen use: impact on vitamin D levels in cutaneous lupus erythematosus.
Authors
Cusack, CaitrionaDanby, Claire
Fallon, Jason C
Ho, Wen Lyn
Murray, Barbara
Brady, Jennifer
O'Kelly, Patrick
Ambrose, Nicola
Kearns, Grainne
Murphy, Gillian M
Affiliation
Department of Dermatology, Beaumont Hospital, Dublin, Ireland.Issue Date
2008-10MeSH
AdultAged
Calcitriol
Cholecalciferol
Female
Humans
Lupus Erythematosus, Cutaneous
Male
Middle Aged
Seasons
Skin
Sunlight
Sunscreening Agents
Metadata
Show full item recordCitation
Photoprotective behaviour and sunscreen use: impact on vitamin D levels in cutaneous lupus erythematosus. 2008, 24 (5):260-7 Photodermatol Photoimmunol PhotomedJournal
Photodermatology, photoimmunology & photomedicineDOI
10.1111/j.1600-0781.2008.00373.xPubMed ID
18811868Additional Links
http://www.ncbi.nlm.nih.gov/pubmed/18811868Abstract
Sun exposure of the skin, independent of dietary sources, may provide sufficient vitamin D in healthy individuals. A recent study of patients with cutaneous lupus erythematosus concluded that over 70% of them restrict their sun exposure.We recruited 52 patients with biopsy-proven cutaneous lupus erythematosus to establish whether they are deficient in 25-hydroxyvitamin D [25(OH)D]. We measured their serum 25(OH)D levels during summer months, investigated the effects of several variables on 25(OH)D levels and assessed the role of vitamin D supplementation.
An overall mean 25(OH)D level of 63.03 (+/-23.3) nmol/l was obtained. Significantly low values (<25 nmol/l) were recorded in two (3.8%) patients and concentrations below 75 nmol/l were found in 34 (65.4%) patients. 25(OH)D levels were significantly lower among sun avoiders and daily sunscreen users, while significantly higher values were found among those who took cholecalciferol (vitamin D3) supplements. Low values were recorded among those with renal disease despite supplementation with vitamin D3 in some cases.
We suggest that patients with cutaneous lupus erythematous have suboptimal 25(OH)D levels, which are significantly raised by the addition of at least 400 IU/day of cholecalciferol. We recommend supplementation with an active vitamin D analogue in collaboration with a consultant nephrologist, for the subgroup of patients with renal disease.
Item Type
ArticleLanguage
enISSN
1600-0781ae974a485f413a2113503eed53cd6c53
10.1111/j.1600-0781.2008.00373.x
Scopus Count
Collections
Related articles
- Optimal sunscreen use, during a sun holiday with a very high ultraviolet index, allows vitamin D synthesis without sunburn.
- Authors: Young AR, Narbutt J, Harrison GI, Lawrence KP, Bell M, O'Connor C, Olsen P, Grys K, Baczynska KA, Rogowski-Tylman M, Wulf HC, Lesiak A, Philipsen PA
- Issue date: 2019 Nov
- Sunlight exposure behaviour and vitamin D status in photosensitive patients: longitudinal comparative study with healthy individuals at U.K. latitude.
- Authors: Rhodes LE, Webb AR, Berry JL, Felton SJ, Marjanovic EJ, Wilkinson JD, Vail A, Kift R
- Issue date: 2014 Dec
- Effect of vitamin D3 seasonal supplementation with 1500 IU/day in north Italian children (DINOS study).
- Authors: Mazzoleni S, Magni G, Toderini D
- Issue date: 2019 Jan 28
- All-source basal vitamin D inputs are greater than previously thought and cutaneous inputs are smaller.
- Authors: Heaney RP, Armas LA, French C
- Issue date: 2013 May
- Sunscreens block cutaneous vitamin D production with only a minimal effect on circulating 25-hydroxyvitamin D.
- Authors: Libon F, Courtois J, Le Goff C, Lukas P, Fabregat-Cabello N, Seidel L, Cavalier E, Nikkels AF
- Issue date: 2017 Dec